CAVERNOSA CORP

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Xiaflex® Plus Testosterone Treatment Pilot Study Protocol

Phase 4
Completed
Conditions
Interventions
First Posted Date
2019-01-24
Last Posted Date
2020-12-31
Lead Sponsor
Men's Health Boston
Target Recruit Count
20
Registration Number
NCT03815331
Locations
🇺🇸

Men's Health Boston, Chestnut Hill, Massachusetts, United States

Subcutaneous vs. Intramuscular Testosterone

First Posted Date
2017-03-27
Last Posted Date
2019-10-08
Lead Sponsor
Men's Health Boston
Target Recruit Count
4
Registration Number
NCT03091348
Locations
🇺🇸

Men's Health Boston, Chestnut Hill, Massachusetts, United States

Diurnal Testosterone Concentration

Completed
Conditions
First Posted Date
2017-03-27
Last Posted Date
2018-03-27
Lead Sponsor
Men's Health Boston
Target Recruit Count
24
Registration Number
NCT03091296
Locations
🇺🇸

Men's Health Boston, Chestnut Hill, Massachusetts, United States

Metabolomics During Testosterone Therapy

First Posted Date
2013-10-16
Last Posted Date
2018-04-19
Lead Sponsor
Men's Health Boston
Target Recruit Count
60
Registration Number
NCT01963390
Locations
🇺🇸

Men's Health Boston, Chestnut Hill, Massachusetts, United States

Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease

First Posted Date
2012-04-17
Last Posted Date
2018-03-29
Lead Sponsor
Men's Health Boston
Target Recruit Count
75
Registration Number
NCT01578473
Locations
🇺🇸

Men's Health Boston, Chestnut Hill, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath